Enovis - 17 Year Stock Price History | ENOV
Historical daily share price chart and data for Enovis since 2008 adjusted for splits and dividends. The latest closing stock price for Enovis as of April 21, 2025 is 32.21.
- The all-time high Enovis stock closing price was 128.86 on July 01, 2014.
- The Enovis 52-week high stock price is 56.43, which is 75.2% above the current share price.
- The Enovis 52-week low stock price is 29.32, which is 9% below the current share price.
- The average Enovis stock price for the last 52 weeks is 44.17.
| Enovis Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 40.6319 | 44.3000 | 47.9900 | 30.6600 | 32.2100 | -26.60% |
| 2024 | 49.9288 | 55.4400 | 63.8000 | 38.7200 | 43.8800 | -21.67% |
| 2023 | 55.7392 | 54.4000 | 65.9200 | 43.6700 | 56.0200 | 4.67% |
| 2022 | 60.2850 | 79.8728 | 80.7843 | 44.8300 | 53.5200 | -32.31% |
| 2021 | 78.4859 | 63.7400 | 91.1038 | 63.7400 | 79.0644 | 20.21% |
| 2020 | 53.1074 | 63.6540 | 66.9046 | 25.1795 | 65.7695 | 5.11% |
| 2019 | 48.9639 | 35.9634 | 62.7081 | 34.7251 | 62.5705 | 74.07% |
| 2018 | 54.7331 | 68.4870 | 71.8236 | 33.0223 | 35.9462 | -47.25% |
| 2017 | 67.9065 | 63.4648 | 74.2315 | 59.9906 | 68.1430 | 10.27% |
| 2016 | 50.2422 | 40.8307 | 68.3666 | 33.1771 | 61.7965 | 53.88% |
| 2015 | 69.9124 | 89.6763 | 91.9638 | 37.8381 | 40.1600 | -54.72% |
| 2014 | 110.4694 | 108.6810 | 128.8560 | 81.1799 | 88.6959 | -19.03% |
| 2013 | 87.5806 | 72.2192 | 109.5410 | 69.5533 | 109.5410 | 57.84% |
| 2012 | 56.9873 | 48.5876 | 69.3985 | 42.6539 | 69.3985 | 41.68% |
| 2011 | 40.1237 | 32.2484 | 54.6932 | 31.2508 | 48.9831 | 54.70% |
| 2010 | 22.9512 | 21.2925 | 32.5064 | 17.6463 | 31.6636 | 52.91% |
| 2009 | 16.6750 | 18.5063 | 23.4424 | 9.3047 | 20.7078 | 15.88% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.825B | $2.108B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $35.134B | 48.53 |
| Tempus AI (TEM) | United States | $6.966B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.050B | 97.25 |
| Inspire Medical Systems (INSP) | United States | $4.470B | 86.83 |
| IRhythm Technologies (IRTC) | United States | $3.223B | 0.00 |
| Privia Health (PRVA) | United States | $2.873B | 215.27 |
| Schrodinger (SDGR) | United States | $1.881B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.839B | 0.00 |
| Omnicell (OMCL) | United States | $1.418B | 30.59 |
| Phreesia (PHR) | United States | $1.409B | 0.00 |
| Azenta (AZTA) | United States | $1.154B | 53.72 |
| 10x Genomics (TXG) | United States | $0.918B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.568B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.551B | 0.00 |
| Talkspace (TALK) | United States | $0.450B | 267.00 |
| Veradigm (MDRX) | United States | $0.449B | 0.00 |
| Standard BioTools (LAB) | United States | $0.440B | 0.00 |
| TruBridge (TBRG) | United States | $0.363B | 0.00 |
| Claritev (CTEV) | United States | $0.325B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.270B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.206B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.189B | 0.00 |
| Pulmonx (LUNG) | United States | $0.182B | 0.00 |
| American Well (AMWL) | United States | $0.109B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.100B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.082B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.076B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.066B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| CareCloud (CCLD) | United States | $0.060B | 2.58 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| Outset Medical (OM) | United States | $0.040B | 0.00 |
| Zepp Health (ZEPP) | China | $0.039B | 0.00 |
| Zhongchao (ZCMD) | China | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Syra Health (SYRA) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |